ONPATH WITH OTARMENI
LIVE

Serial Number

99562098

Owner

Regeneron Pharmaceuticals, Inc.

Attorney

Jeffrey J. Scepanski

Filing Date

Dec 22, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ONPATH WITH OTARMENI Trademark

Serial Number: 99562098

ONPATH WITH OTARMENI is a trademark filed by Regeneron Pharmaceuticals, Inc. on December 22, 2025. The trademark is classified under Class 36 (Insurance & Financial), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Regeneron Pharmaceuticals, Inc. (22 trademarks)

777 Old Saw Mill River Road
Tarrytown, NY 10591

Entity Type: 03

Trademark Details

Filing Date

December 22, 2025

Registration Date

Not Registered

Published for Opposition

May 26, 2026

Goods & Services

Medical assistance services in the field of treatment of auditory and neurological diseases and disorders; Providing medical information regarding diagnosis and treatment of auditory and neurological diseases and disorders

Business administration services, namely, business administration of a program to provide access to medicines at low or no cost to underserved populations; Business administration services, namely, business administration of a program to provide discounts on prescription medicines

Financial administration services, namely, financial administration of a program to provide access to medicines at low or no cost to underserved populations; Financial administration services, namely, financial administration of a program to provide discounts on prescription medicines

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 26, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 26, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 20, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 1, 2026 CNSA
ASSIGNED TO EXAMINER
Apr 24, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 14, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Dec 22, 2025 MAFR
NEW APPLICATION ENTERED
Dec 22, 2025 NWAP